Savillex, LLC has completed its acquisition of Entegris, Inc.'s Life Sciences Fluid Management business, adding a portfolio of single-use bioprocessing and pharmaceutical manufacturing products to its high-purity fluid handling range.
The acquired portfolio includes Aramus and PE bags, single-use assemblies and components used across discovery, clinical and commercial manufacturing. Savillex, based in Eden Prairie, Minn., said the transaction expands the breadth of its life sciences offerings with a larger set of high-performance single-use solutions. Entegris is based in Billerica, Mass.
As part of the deal, Savillex gains the Life Sciences Fluid Management team and its technologies in high-purity fluid management. The company said customers can expect more single-use options, additional technical expertise and enhanced capabilities to support critical applications from early-stage research through commercial manufacturing.
Savillex said that combining these complementary strengths positions it to deliver greater value, and that the combined capabilities are intended to help customers simplify increasingly complex bioprocessing workflows.
Portfolio fit and customer reach
Eric Giesing, chief executive officer of Savillex, said the acquired business has built a strong reputation in high-purity single-use bioprocessing and that the Aramus product line is a natural fit alongside Savillex's Savillex, Containment and Bioprocessing offerings. He said the acquisition expands the company's portfolio and enables it to deliver a broader range of innovative solutions to biopharmaceutical and pharmaceutical customers.
Giesing added that Savillex is welcoming the team behind the business and will continue investing in technologies that help customers accelerate the development and production of critical therapies.
Chris Bedi, general manager of Fluid Management at Savillex, said the acquisition creates an opportunity to bring a broader portfolio of high-value fluid management solutions to pharmaceutical and biopharmaceutical customers worldwide. He said the Fluid Management portfolio complements Savillex's existing capabilities and that the combined organization will continue to provide innovative solutions while expanding its ability to support partners across the continuum of drug development.
Bedi also said the company is excited by the opportunity to help customers bring transformative new medicines to patients around the world.
Strategy and advisers
Savillex said the acquisition advances its strategy of delivering industry-leading solutions for the life sciences market. The company said it remains committed to investing in innovation, quality and customer partnership while expanding its portfolio to meet the evolving needs of biopharmaceutical and pharmaceutical manufacturers worldwide.
The terms of the transaction were not disclosed. EC M&A, based in New York, served as financial advisor to Savillex, and Sidley Austin LLP, based in Chicago, served as legal counsel.